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Abstract
Background: In this study, we tested the hypothesis that 17β-estradiol contributes to
testosterone-mediated restoration of baroreflex-mediated bradycardia in short-term (3 weeks)
castrated rats. Further, a reported increase in serum testosterone after long-term (6 weeks)
castration constituted a basis for testing the hypothesis that a spontaneous increase in serum
testosterone or androstenedione in this model causes a commensurate increase in baroreflex-
mediated bradycardia.
Results: Testosterone (1 week) replacement enhanced baroreflex-mediated bradycardia in short-
term castrated rats without changing 17β-estradiol level. A spontaneous recovery of baroreflex-
mediated bradycardia occurred following long-term castration, although circulating testosterone
and androstenedione remained suppressed.
Conclusion: The data suggest: 1) 17β-Estradiol does not contribute to testosterone restoration
of the baroreflex-mediated bradycardia in short-term castrated rats. 2) The long-term modulation
of baroreflex-mediated bradycardia occurs independent of androgens, or the baroreflex
mechanism may become adapted to low levels of circulating androgens.
Background
Short-term castration attenuates the vagal component of
baroreflex sensitivity in sexually mature male rats [1,2].
Factors influencing baroreflex sensitivity include gender,
age, baseline mean arterial pressure and heart rate,
anesthesia, and the method of drug administration [3-9].
However, these factors cannot account for the difference
in baroreflex sensitivity between intact and castrated rats
in reported studies [1,2].
El-Mas et al. [1,2] have shown that testosterone replace-
ment restores baroreflex-mediated bradycardia in short-
term castrated rats. Further, we and others [4,10] have
demonstrated that 17β-estradiol enhances baroreflex sen-
sitivity. Notably, 17β-estradiol is a product of testosterone
aromatization by the aromatase enzyme [11], which
raises its possible contribution to testosterone effects on
baroreflex sensitivity. This latter possibility has not been
investigated. Further, Ando et al. [12] demonstrated a
reflex increase in circulating testosterone of adrenocortical
origin subsequent to long-term (6 weeks) castration. The
impact of such an increase in serum testosterone on
baroreflex sensitivity is not known. Hence, the main
objective of this study was to test the hypotheses that (i)
17β-estradiol, contributes to testosterone restoration of
the vagal component of baroreflex sensitivity in short-
term (3 weeks) castrated rats, and (ii) the spontaneous
increase in serum testosterone, or androstenedione,
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reported by others [12] in long-term (6 weeks) castrated
rats results in proportionate increase in baroreflex sensi-
tivity. This goal was achieved by determining whether a)
Testosterone replacement (1 week) restores the attenuated
baroreflex sensitivity in short-term castrated rats, b)
Serum 17β-estradiol increases in testosterone-treated rats,
and c) An increase in baroreflex sensitivity occurs in long-
term castrated rats along with an increase in serum testo-
sterone or androstenedione. These studies were under-
taken in conscious unrestrained rats to avoid the
confounding effects of anesthetics on the measured varia-
bles [3].
Results
Effect of testosterone replacement on baroreceptor reflex 
control of heart rate
Baseline mean arterial pressure values, measured on the
day of the experiment, were similar between the orchiect-
omized/testosterone and orchiectomized/vehicle rats
(Table 1). However, the orchiectomized/testosterone rats
exhibited a significantly (P < 0.05) lower baseline heart
rate compared with the orchiectomized/vehicle rats
(Table 1). Phenylephrine elicited similar rises in mean
arterial pressure in all groups (data not shown). However,
the similar increments in mean arterial pressure were
accompanied by greater reflex bradycardic responses in
the orchiectomized/testosterone compared with the
orchiectomized/vehicle rats (data not shown). Therefore,
baroreflex-mediated bradycardia was significantly
enhanced in orchiectomized/testosterone compared with
the orchiectomized/vehicle rats (-1.82 ± 0.15 vs. -1.43 ±
0.1 beats min-1 mmHg-1; P < 0.05, Figure 1C). In addition,
serum testosterone increased to within physiological lev-
els in orchiectomized/testosterone rats (P < 0.001, Figure
1A). There was no change in serum 17β-estradiol in
orchiectomized/testosterone compared with orchiect-
omized/vehicle rats (Figure 1B).
Effect of long-term castration on baroreceptor reflex 
control of heart rate
Baseline mean arterial pressure and heart rate values,
measured on the day of the experiment, were similar
between the sham-operated and long-term castrated
groups of rats (Table 1). Phenylephrine elicited similar
rises in mean arterial pressure in all groups (data not
shown). In addition, at any given rise in blood pressure,
the reflex bradycardic response was similar in long-term
castrated rats to that of the sham-operated rats (data not
shown). Therefore, baroreflex-mediated bradycardia was
restored compared with the sham-operated rats (-2.20 ±
0.35 vs. -2.29 ± 0.24 beats min-1 mmHg-1; P > 0.05, Figure
2C). Finally, the restoration of baroreflex sensitivity sub-
sequent to long-term castration occurred in the presence
of significantly (P < 0.001) lower circulating levels of tes-
tosterone and androstenedione compared with the sham-
operated rats (Figures 2A and 2B). Comparison of the data
obtained from short-term vs. long-term castrated rats
revealed that the baroreflex-mediated bradycardia under-
went a phase of inhibition at the 3rd week, but such inhi-
bition was no longer evident by the 6th week after
castration (Figure 2C). Notably, serum testosterone deple-
tion, observed 3 weeks after castration, continued to be
evident 6 weeks after castration (Figure 2A). Therefore, no
correlation was observed between baroreflex sensitivity
and serum testosterone (r = 0.2, P > 0.05).
Discussion
The current study presents 3 new findings. First, testoster-
one replacement (1 week) restores baroreflex sensitivity
(baroreflex-mediated bradycardia) to control level, but
17β-estradiol does not contribute to this action in short-
term (3 weeks) castrated rats. Second, baroreflex-medi-
ated bradycardia spontaneously recovers to sham-opera-
tion level subsequent to long-term (6 weeks) castration,
which suggests that the restoration of baroreflex-mediated
bradycardia is time-dependent. Third, the spontaneous
recovery of baroreflex sensitivity occurs in spite of signifi-
cantly suppressed circulating levels of testosterone and
androstenedione. This suggests that the long-term modu-
lation of baroreflex sensitivity occurs independent of
androgens, or the baroreflex mechanism may become
adapted to low levels of circulating androgen.
Table 1: Baseline mean arterial pressure (MAP) and heart rate (HR) of orchiectomized/testosterone (O/T), orchiectomized/vehicle 
(O/V), long-term castrated (L.T.C.), and sham-operated (SO) rats. The rats were allowed to acclimatize to laboratory conditions for 
at least 2 h prior to experimentation and a period of at least 30 min was allowed after connecting the rat to the pressure transducer 
for stabilization of blood pressure and heart rate. a P < 0.05 vs orchiectomized/vehicle.
Group n MAP (mmHg) HR (beats/min)
O/T 21 108 ± 2.6 392 ± 6a
O/V 14 105 ± 1.7 427 ± 10
L.T.C. 12 109 ± 4.1 414 ± 9
S.O. 5 102 ± 1.8 421 ± 14
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Effect of testosterone depletion and replacement on barore-flex sensi ivi y and serum hormone levelsFigure 1
Effect of testosterone depletion and replacement on 
baroreflex sensitivity and serum hormone levels. 
Serum testosterone (A) and 17β-estradiol (B) level and 
baroreflex sensitivity (C) in conscious unrestrained male rats 
following orchiectomy (3 weeks) and 1-week treatment with 
testosterone or vehicle. Data are means ± SEM. Numbers in 
parentheses are number of observations. Orchiectomized/
testosterone (O/T), orchiectomized/vehicle (O/V). * P < 
0.05, *** P < 0.001 vs. orchiectomized/vehicle.
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Effect of long-term castration on baroreflex sensitivity and serum hormon  levelFig re 2
Effect of long-term castration on baroreflex sensitiv-
ity and serum hormone levels. Serum testosterone (A) 
and androstenedione (B) level and baroreflex sensitivity (C) 
in conscious unrestrained rats 6 weeks after castration (long-
term castration or L.T.C.) or sham-operation (SO). Data are 
means ± SEM. Numbers in parentheses are number of obser-
vations. *** P < 0.001 vs. sham-operated.
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In the present study we investigated the possibility that
17β-estradiol derived by the aromatization of testosterone
[11] contributed to the testosterone-mediated increase in
baroreflex-mediated bradycardia recently reported by El-
Mas et al. [1,2]. Because Saleh and Connell [10] have
shown that 17β-estradiol enhances the baroreflex-medi-
ated bradycardia of male rats, we reasoned that testoster-
one enhancement of baroreflex sensitivity in castrated
rats, might be secondary to the conversion of testosterone
to 17β-estradiol. As previously shown [1,2] we demon-
strated that testosterone replacement, which resulted in
physiological levels of plasma testosterone, increased
baroreflex-mediated bradycardia. Results of the present
study showed that serum 17β-estradiol level did not
change in testosterone-treated rats, which suggests that
17β-estradiol does not contribute to the action of testo-
sterone on baroreflex control of heart rate following testo-
sterone replacement. Hence, testosterone or another
androgenic metabolite(s) seems to mediate the enhanced
baroreflex response in short-term castrated rats. This
notion is consistent with our preliminary finding that
demonstrates the importance of the androgen receptor in
the enhancement of baroreflex sensitivity in male rats
[16].
The enhanced baroreflex-mediated bradycardia by testo-
sterone replacement observed in this study and by others
[1,2] together with the compensatory reflex increase in
serum testosterone by the adrenal cortex, subsequent to
long-term (6 weeks) castration [12], raised the interesting
possibility that such an increase in endogenous testoster-
one may result in a proportionate increase in baroreflex-
mediated bradycardia. Indeed, baroreflex-mediated
bradycardia spontaneously recovered after long-term (6
weeks) castration to the sham-operation level. This find-
ing supported our hypothesis and suggests that the resto-
ration of baroreflex sensitivity after castration is time-
dependent.
Contrary to our expectation and in disagreement with
reported findings in a similar animal model [12], serum
testosterone remained significantly suppressed in our ani-
mals. The discrepancy between both studies may be attrib-
uted to the antibody used by Ando et al. [12] to measure
serum testosterone, which exhibited 40% cross-reactivity
with dihydrotestosterone (a major product of testoster-
one) vs. 4% in our study. Nonetheless, the spontaneous
and complete recovery of baroreflex-mediated bradycar-
dia in the presence of significantly suppressed serum tes-
tosterone raised the following possibilities. Androgens
other than testosterone (particularly androstenedione)
may have enhanced baroreflex-mediated bradycardia sub-
sequent to long-term castration (6 weeks), because (i)
serum androstenedione increased to pre-castration levels
6 weeks after castration [12], and (ii) Labrie et al. [16]
demonstrated that flutamide, a competitive nonsteroidal
antiandrogen, which attenuated baroreflex-mediated
bradycardia in our preliminary study [17], antagonized
the effect of androstenedione at the androgen receptor.
Since we observed no change in serum androstenedione
subsequent to long-term castration, which again disagrees
with reported findings [12], the present findings suggest
that androstenedione, like testosterone, may not play a
role in the spontaneous recovery of baroreflex-mediated
bradycardia. The discrepancy between both studies may
be attributed to a lower recovery rate (<65%) for andros-
tenedione by Ando et al. [12] vs. a higher recovery rate
(>80%) in this study.
An alternate explanation for the spontaneous recovery of
baroreflex sensitivity in the presence of suppressed testo-
sterone and androstenedione is that the baroreceptor
reflex mechanism may have become adapted to the low
level of circulating androgens. This would suggest an asso-
ciation between long-term castration, and the activation
of compensatory mechanisms possibly involving an
increase in androgen receptor density and/or signaling. Yu
and McGinnis [18] reported a decrease in androgen recep-
tor density in the nucleus ambiguus (one of the nuclei
implicated in the baroreceptor heart rate response) [19] at
2 weeks castration, a period that coincides with a signifi-
cant attenuation of baroreflex sensitivity observed in the
present study and by others [1,2]. Whether an
upregulation of androgen receptors in the brainstem
occurs 6 weeks after castration remains to be investigated.
Conclusion
Testosterone contributes to the maintenance of barore-
flex-mediated bradycardia in adult rats. Such a physiolog-
ical role for testosterone seems to manifest only on a
short-term basis because: (i) Short-term (3 weeks) castra-
tion caused a significant reduction in baroreflex-mediated
bradycardia, a deficit corrected by testosterone replace-
ment. (ii) Spontaneous recovery of baroreflex-mediated
bradycardia occurred following long-term (6 weeks) cas-
tration in spite of the continued suppressed testosterone
and androstenedione levels, which may argue against a
long-term effect of testosterone or androstenedione on
baroreflex-mediated bradycardia. Circulating androgens
other than testosterone and androstenedione may con-
tribute to the restoration of baroreflex-mediated bradycar-
dia subsequent to long-term castration. An alternate
possibility, that remains to be investigated, is that the
baroreceptor reflex mechanism may have become
adapted to the low level of circulating androgens.
Methods
Preparation of the rats
Male Sprague-Dawley rats (Harlan Farms, Indianapolis,
IN) were used in this study. Arterial blood pressure was
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measured according to the method used in our previous
studies [4]. Briefly, the rats were anesthetized with meth-
ohexital sodium (50 mg kg-1, i.p.). Catheters (polyethyl-
ene 10 connected to polyethylene 50), which were filled
with heparinized saline (100 U ml-1), were placed in the
abdominal aorta and vena cava via the femoral artery and
vein for measurement of blood pressure and i.v. adminis-
tration of drugs, respectively. The catheters were inserted
about 5 cm into the femoral vessels and secured in place
with sutures. Finally, the catheters were tunnelled s.c.,
exteriorized at the back of the neck between the scapulae,
and plugged by stainless steel pins. Incisions were closed
by surgical staples and swabbed with povidone-iodine
solution. Each rat received s.c. injection of buprenorphine
hydrochloride (Buprenex; 0.3 µg rat-1) to control pain and
an i.p. injection of 50,000 U kg-1 of penicillin G benza-
thine and penicillin G procaine in an aqueous suspension
(Durapen) and was housed in a separate cage. The exper-
iment was started 48 h later, which involved the connec-
tion of the arterial catheter to a Gould-Statham pressure
transducer (Oxnard, CA). The blood pressure was dis-
played on a Grass polygraph (model 7D, Grass Instru-
ments Co., Quincy, MA). Heart rate was computed from
blood pressure waveforms by a Grass tachograph and was
displayed on another channel of the polygraph.
Experiments were performed in strict accordance with
institutional animal care and use guidelines, and in
accordance with the principles and guidelines of the
National Institutes of Health Guide for the Care and Use
of Laboratory Animals.
Orchiectomy
Bilateral orchiectomy was performed as described [13]
and according to an approved protocol by the institu-
tional animal care and use committee. Under methohexi-
tal sodium (50 mg kg-1, i.p.) anesthesia, a small surgical
incision was made in the center of the scrotum. Each tes-
ticle was exposed through the surgical orifice. The ductus
deferens and main arteries and veins were isolated and
ligated. Subsequently, the duct and blood vessels were
severed allowing the testicle and epididymis to be
removed. The incision was then closed, sutured and
swabbed with povidone-iodine solution. The sham
operation involved the exposure of the testes without iso-
lation. The post-operative procedure was implemented as
previously described. Finally, the rats were housed in sep-
arate cages and allowed free access to food and water.
Radioimmunoassays
The commercially available radioimmunoassay "Coat-A-
Count Total Testosterone", "Coat-A-Count Direct Andros-
tenedione" and "Double Antibody Estradiol" kits were
used for the analysis of serum testosterone,
androstenedione, and 17β-estradiol, respectively, and
were purchased from Diagnostic Products Corporation
(Los Angeles, CA).
Protocols and experimental groups
Effect of testosterone replacement on baroreceptor reflex control of 
heart rate
Two groups of conscious unrestrained rats (orchiect-
omized 3 weeks earlier at 250–275 g; orchiectomized/tes-
tosterone: n = 21 and orchiectomized/vehicle: n = 14),
weighing 325–350 g, were used in this experiment to
investigate whether (i) testosterone replacement restores
the baroreflex heart rate response, and (ii) 17β-estradiol
contributes to testosterone restoration of baroreflex sensi-
tivity. Silastic implants (inner diameter, 2.6 mm; length,
25 mm; outer diameter, 3.1 mm; Konigsberg Instruments,
Inc, Pasadena, CA) containing crystallized testosterone
(or empty implants for controls) were subcutaneously
implanted (for 1 week) within the orchiectomized rats
according to the method used in previous studies [14].
The post-operative procedure was implemented as previ-
ously described. On the day of the experiment, the rats
were allowed to acclimatize to laboratory conditions for
at least 2 h prior to experimentation. Subsequently, the
arterial catheter was connected to a pressure transducer for
measurement of blood pressure and heart rate. Blood
samples (0.6 ml) were collected, from the femoral artery,
for measurements of serum testosterone and 17β-estra-
diol levels. A period of 30 min was then allowed for
further stabilization of blood pressure and heart rate.
Baroreflex curves were constructed in all rats by the i.v.
bolus injection of randomized doses of phenylephrine
(1–16 µg kg-1) at 5-min intervals. Phenylephrine was dis-
solved in saline and administered in varying volumes of a
stock concentration (36 µg ml-1) of phenylephrine to
achieve the desired doses. Each experiment lasted approx-
imately 1 h. The peak changes in mean arterial pressure
and heart rate, obtained following phenylephrine injec-
tions, were used for the construction of the baroreflex
curves.
Effect of long-term castration on baroreceptor reflex control of heart 
rate
Two groups of rats (orchiectomized n = 12, or sham-oper-
ated n = 5, 6 weeks earlier at 175–200 g), weighing 325–
350 g on the day of the experiment, were used to investi-
gate whether a reflex adrenocortical increase in testoster-
one or androstenedione, subsequent to long-term
castration, results in a proportionate increase in baroreflex
sensitivity. Blood samples (0.6 ml) were collected, from
the femoral artery, prior to each experiment for the analy-
sis of serum testosterone and androstenedione levels.
Baroreflex-mediated bradycardia was assessed as previ-
ously described.
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Drugs
Phenylephrine hydrochloride (Sigma Chemical Co., St.
Louis, MO), crystalline testosterone (Sigma Chemical Co.,
St. Louis, MO), methohexital sodium (Eli Lilly and Com-
pany, Indianapolis, IN), Buprenex (buprenorphine
hydrochloride; Rickitt & Colman, Richmond, VA), povi-
done-iodine solution (Norton Co., Rockford, IL), and
Durapen (penicillin G benzathine and penicillin G pro-
caine; Vedco, Overland Park, KS) were purchased from
commercial vendors.
Statistical analysis
Values are expressed as means ± SEM. The relationship
between increases in mean arterial pressure (Mean Arte-
rial Pressure = diastolic pressure + one-third {systolic -
diastolic pressures}) and associated decreases in heart
rate was assessed by regression analysis for individual ani-
mals as described in our previous studies [4]. The regres-
sion coefficient (slope of the regression line) expressed as
beats min-1 mmHg-1 was taken as an index of baroreflex-
mediated bradycardia [4]. Analysis of variance (ANOVA)
followed by Fisher's Least Significant Difference post hoc
analysis was used for multiple comparisons. The Student's
t-test was used in the analysis of unpaired data, with the
level of significance set at P < 0.05. In accordance with
reported criteria, control rats possessing (i) baroreflex sen-
sitivity values with significant (P < 0.05) correlation coef-
ficients greater than or equal to 0.8 [8], and (ii) serum
testosterone levels greater than or equal to 60 ng/dl [15]
were included in the data analysis.
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